Articles
Original papers
A clinical pharmacological study of the effect of clomipramine and protriptyline on the uptake of tritiated 5HT and DA in platelets from depressed patients ’ Hallström C, Pare M, Rees W, Trenchard A & Turner P Journal de Pharmacologie, Supp No. 2 1975
Platelet uptake of 5HT and dopamine in depression - Hallström C, Pare M, Linford-Rees M, Trenchard A & Turner P Postgraduate Medical Journal 1976 52, 40-44
Antidepressant blood levels in acute overdose - Hallström C & Gifford L Postgraduate Medical Journal 1976 52, 687-688
E, C, G, changes on Butriptyline - Hallström C & Brooks N Communication in Psychopharmacology 1979 3, 55-59
Diazepam and its metabolite nordiazepam, in saliva, plasma and CSF - Hallström C, Lader M & Curry S British Journal of Clinical Pharmacology 1980 9, 333-339
A stable isotope dilution assay for the antiparkinsonian drug benzotropine in biological fluids - Jindal S, Lutz T, Hallström C & Vestergaard P Clinical Chimica Acta 1981 112, 267-273
The effects of propranolol and diazepam alone and in combination, on the effects of chronic anxiety - Hallström C, Treasaden I, Edwards G & Lader M British Journal of Psychiatry 1981 139, 417-421
Protection of patients on MAOIs against hypertensive crises - Kline N, Cooper T, Suckow R, Hallström C & Brebbia Journal of Clinical Psychopharmacology 1981 1, 410-411
Benzodiazepine withdrawal phenomena -Hallström C & Lader M International Pharmacopsychiatry 1981 16, 235-244
The effects of ginseng on physiological, biochemical and psychological measure, after sleep deprivation - Hallström C, Fulder S & Carruthers M American Journal of Chinese Medicine 1982 6, 277-282
The incidence of benzodiazepine dependence - Hallström C & Lader M Journal of Psychiatric Treatment and Evaluation June 1982 4,293-296
Will amitriptyline prevent the "cheese" reaction of monoamine oxidase inhibitors? - Pare M, Kline N, Hallström C & Cooper T Lancet 1982, 183-186
Steady state plasma levels of lofepramine and desipramine monitored during a clinical double-blind comparison: a preliminary report - Hallström C Chapter in Lofepramine in the treatment of depressive disorders™ 1988 Angst J and Wogan B (eds) Vieweg, Braunschweig
Benzodiazepine dependent patients and their psychological treatment - Crouch G, Robson M & Hallström C Progress in Neuropsychopharmacology & Biological Psychiatry 1988 12, 503-510
Rapid response to buspirone: assessment in a general practice setting - Hallström C & Cox J British Journal of Clinical Practice 2: 65-80 (1991)
Self-help and benzodiazepine withdrawal - Tattersall ML and Hallström C Journal of Affective Disorders 24 (1992) 193-198
Inadequate treatment response to des-enkephalin-gamma-endorphin compared with thioridazine and placebo in schizophrenia - Montgomery SA, Hallström C et al Acta Psychiatrica Scandinavica (86) 1992, 97-103
An open study of remoxipride in the long-term treatment of schizophrenia - T Ashwood, C Hallström et al Journal of Psychopharmacology 6(4) 1992 519-525
The role of coping strategies in protecting individuals against long-term tranquilliser use - Bish A, Golombok S, Hallström C, Fawcett S (submitted for publication)
A controlled trial of dothiepin and placebo in treating benzodiazepine withdrawal symptoms - Tyrer P, Ferguson B, Hallström C, Mitchie M, Tyrer S, Cooper S, Caplan R, Barczak P British Journal of Psychiatry (1996) vol 168, page 457-461
Pharmacist™ Mental Health Role Questioned - Hallström C Progress in Neurology and Psychiatry Vol.2 Issue 2 March/April 1998
Abstracts/Articles/Letters
The future of psychiatry - Eds Creed F & Hallström C Geigy Publications, 1979
Prediction of response to anti-anxiety agents - Hallström C & Lader M Proceedings of the 11th CINP, Pergammon Press, 1979
Benzodiazepine withdrawal phenomena - Hallström C & Lader M Abstracts of the 12th CINP Congress 1980, Progress in Neuropsychopharmacology (sup), 186
The use and abuse of tranquillisers - Hallström C Update July 1982 4, 43-50
Which hypnotic - if any? - Hallström C British Journal of Hospital Medicine 1983 30, 188-192
The current view on minor tranquillisers and new developments - Hallström C Postgraduate Doctor 1984 7, 366-372
Practical aspects of the use of beta-blockers in anxiety states: morbid anxiety - Hallström C Postgraduate Medical Journal 1984 60 (supp 2), 26-30
Thyroid abnormalities and violent suicide - Drummond L, Lodrick M & Hallström C British Journal of Psychiatry 1984 144, 213 (Letter)
Specific benzodiazepine receptors: What is the latest thinking? - Hallström C Medical Dialogue 1985 58, 2-4
Patients' attitudes to depot neuroleptics - Hallström C, Halstead S, Hays H Schizophrenia Research 1988 May, 209-210
Anxiolytic drugs; past, present and future - Hallström C Holistic Medicine 1989 4, 157-163
Uses and abuses of benzodiazepines - Hallström C British Journal of Hospital Medicine 1989 41, 115
Benzodiazepines and medical negligence - the issues - Hallström Abstracts of Autumn Quarterly Meeting of The Royal College of Psychiatrists, 1989
Uses and misuses of benzodiazepines - Hallström C, Hawley C Postgraduate Doctor 13: 316-320 (1990)
Medical aspects of benzodiazepine abuse - Hallström C Practical reviews in Psychiatry, 2: 9, 3-5 (1990)
Benzodiazepine and medical negligence - Hallström C Update 40: 1139-1140 (1990)
GBR 12909: a dose response relationship of the selective dopamine uptake inhibitor in major depression - Fensbo C, Montgomery S, Andersen J, Hallström C, Schonbeck G, de Zwann M, Moller Neilsen E, Olafsen K, Ingwersen S: 17th Congress of the Collegium Internationale Neuro-Psychopharmacologicum 1990 (Tokyo)
Buspirone in British general practice - Hallström C 17th Congress of the Collegium Internationale Neuro-Psychopharmacologicum 1990 (Tokyo)
Desenkephalin gamma endorphin and thioridazine in the treatment of schizophrenia; a placebo controlled study - Montgomery S, Green M, Rimon R, Heikkila L, Foresstrom R, Hirsch S, Hallström C, Hippius H, Naber R, Kahn M, Stitsen J: 17th Congress of the Collegium Internationale Neuro-Psychopharmacologicum 1990 (Tokyo)
Benzodiazepine dependent patients in different clinical settings - Hawley C, Crouch G, Tattersall M, Hallström C: British Association for Psychopharmacology Summer Meeting 1990 (Cambridge)
Tranquilliser addiction; medicolegal aspects - Hallström C The Royal College of Psychiatrists Annual General Meeting 1990 (Birmingham)
Benzodiazepine dependence; an incomplete picture - The Royal College of Psychiatrists Annual Meeting 1990 (Birmingham)
Current views on treating patients with anxiety: factors that affect the choice of drug - Hallström C Prescriber Issue 28 34-38 (1991)
The comparison of anxiety rating scales in a training situation
Proceedings of the British Association of Psychopharmacology's Summer Meeting 1991 - Bradford L, Hallström C, Gerristen van der Hoop, Stevens G
Benzodiazepine dependence; who is responsible? - Hallström C (Editorial) The Journal of Forensic Medicine 2: 5-7 (1991)
Appropriate prescribing of the benzodiazepines - Hallström Pulse 51: Page 58 (1991)
Anxiety disorders and their management - Hallström C Prescriber Vol 3, Issue 19 31-38 (1992)
Buspirone - different mode of action reduces anxiety treatment complications - Hallström C Pulse Vol 50: No 21 75
Watch out for depression in sleep disorder cases - Hallström C Mims Magazine Vol 19 No 21 55 (1992)
Prophylactic therapy in depression - Mims Magazine (1992)
Guidelines for the management of patients with generalised anxiety (Consensus Panel) Psychiatric Bulletin, 1992 16, 560-565
Guidelines for the management of patients withdrawing from benzodiazepines - Mental Health Foundation 1993
Guidelines for the treatment of depressive illness with antidepressants - Montgomery S, Hallström, et al Journal of Psychopharmacology 1993 7: 19-23
Guidelines for the investigation of anti-anxiety drugs (Consensus Panel) British Association for Psychopharmacology (In press)
Antidepressants in the treatment of anxiety disorder - Tyrer P & Hallström C Psychiatric Bulletin 1993 Vol 17 75-76
ECT causes an increase in urinary output of the monoamine oxidase An inhibitory component of Tribulin - Clow A, Kimber S, Sandler M, Hallström C, Hawley C, Glover V (Abstract) British Association of Psychopharmacology Meeting, 1993
Reading list for MRCGP examination on depression - MIMS Magazine, October 5th 1993
Drugs in focus: Zopiclone - Prescriber Journal. 34. 115-119: 1994
Reshaping mental health services. (Review) - The Psychiatric Bulletin.
Waving a goodbye to mother's little helper Focus on drug dependency - featuring Dr Hallström Hospital Doctor 29 May 1993
Mental health care is worsening by the day (Letter to the Editor) Evening Standard 13 1 1995 Hallström C, Hirsch S
What are the options for GPs when prescribing hypnotics? - MIMS Weekly 4 10 94 Hallström C
Rational choices in CNS prescribing: the cost of depression - Prescriber 5:15 1994 24 - 29
Hypnotics - MIMS Weekly 1995 Hallström C
Costs of clozapine - Bulletin of The Royal College of Psychiatrists 1995 Bottomley C, Hallström C
The rating of depression - Perspectives in Depression 4: 3 1996 1-5 Hallström C
More ECT needed not less (Opinion) - Care of the Elderly 7 No 3 1995 Hallström C
Can GPs manage without benzodiazepines - Prescriber (in press)
Tranquillisers are good for you? - Proceedings of The Medical Society of London (in press)
Managing minor psychiatric conditions in adolescents - Prescriber 19 January 1997 Hill-Smith A, Hallström C
Medico-legal Aspects of Occupational Stress - Journal of the Medico-legal Society 1997 Hallström C
Hyperkinetic Disorder Progress in Neurology and Psychiatry - Nov/Dec 1997 Hill-Smith A & Hallström C
Mania, Schizophrenia and the Mental Health Act - Update June 1997 842-851 Hallström C
Pocket Guide to Insomnia - 1997 Advisory Panel
The Drug Management of Schizophrenia - The Practitioner (in press 1998)
The Pharmacotherapy of Schizophrenia - The Practitioner January 1998 Vol.242 Hallström C, Magnes R
Stress and Mental Health Nursing Mental Health Care - Hallström C, (in press 1988)
Benzodiazepine Dependence 20 Years On Progress in Neurology and Psychiatry - Hallström C, (in press)
Differentiating anxiety from physical disorder in primary care - Psychiatry Reviews, Vol 2, No 3 Autumn 1997 Hallström C, Galloway C
Royal College of Psychiatrists Statement on Benzodiazepines - 1997 (co-author)
Stigma of Anxiety Hospital Medicine - 1999 Hallström C
A Primary-care Guide to Insomnia Management - Prescriber 5 April 200 Hallström C
Contributors to Drugs and Therapeutic Bulletin
Tranquilliser independence (Self-help audio cassette for patients)
Clinical Trials
1974
Amitriptyline vs butriptyline in depressed outpatients Phase 3
Clomipramine vs protriptyline in depressed outpatients - monitoring platelet uptake of 5-HT and dopamine. Clinical pharmacological study.
1976 - 1990
Diazepam, propranolol and their combination for the treatment of chronic anxiety Clinical pharmacological study
A clinical pharmacological study of benzodiazepine withdrawal
Desenkephalin gamma endorphin and thioridazine in the treatment of schizophrenia; a placebo controlled study Phase 2
GRB 11909: A dose response relationship of selective dopamine uptake inhibitor in major depression Phase 2
BRG 21909: A double blind placebo controlled study versus Imipramine for the treatment of major depression. A multicentre multinational study Phase 3
Lofepramine vs desipramine in depressed outpatients A clinical pharmacological study
Propranolol vs placebo in benzodiazepine withdrawal
Clopixol concentrate vs Haldol decanoate in the maintenance treatment of schizophrenia Principal investigator Phase 4
Remoxipride in the longterm treatment of schizophrenia A multicentre study Investigator Long-term safety study
Zacopride: a dose finding study of 5HT3 agonist in anxiety Multicentre study Investigator Phase 2
Investigator in A study of a DA antagonist antidepressant in depressed outpatients Phase 2
Investigator in A multicentre study of Prothiaden vs placebo in the treatment of benzodiazepine withdrawal Phase 4
UKMAS study of calcium homotaurinate in the prevention of relapse in alcoholism Investigator Phase 4
1990 - 1992
Buspirone: assessment in a general practice setting; A study of 670 patients in general practice Principal investigator Phase 4.
Buspirone ER vs Buspirone IR. A multicentre, multinational study in primary care. Principal investigator. Phase 4.
Flesinoxan vs placebo in anxiety A multicentre, multinational study in primary care; Trainer; Phase 3
Nefazodone vs fluoxetine in depressed patients in primary care A multinational study; Principal investigator; Phase 3
1992
Nefazodone vs sertraline in depressed hospital outpatients Investigator; Phase 3
Ondansetron in the prevention of relapse in chronic anxiety
1993
Long-term relapse prevention of fluvoxamine in depression Investigator
Trainer in a study of amisulpiride in schizophrenia
1994
Sertraline vs imipramine in panic disorder
Trainer in a study of an antidepressant A multidimensional study
1995
CLZ-20 499 - 006 -GBR A study of an anxiolytic in generalised anxiety disorder
Relapse prevention in depression of ORG 4428 in outpatients
1998
Paroxetine -v- Placebo in Social Phobia
1999
Investigator in a Study of Antidepressants. ASTRA phase 2.
Paroxetine -v- Placebo in GAD. Phase 3.
Several other studies since – as coordinator/principal investigator






